Aarey Drugs Allots 11.5 Lakh Equity Shares on Warrant Conversion

Aarey Drugs & Pharmaceuticals Ltd announced the allotment of 11,50,000 Equity Shares following the conversion of Fully Convertible Equity Share Warrants. This conversion was approved in the Board Meeting held on September 30, 2026. The warrants were originally issued on a preferential allotment basis at an offer price of ₹63.80 each. The conversion involved receipt of ₹47.85 per warrant, aggregating to ₹5,50,27,500/-. This allotment increases the company's issued and paid-up capital. The company also provided details on the conversion of warrants, noting that 23,70,000 warrants were converted on August 6, 2026, and 11,50,000 on September 30, 2026, with 14,80,000 warrants still outstanding for conversion within their 18-month tenure.